Literature DB >> 277242

The effect of misonidazole in combination with radiation dose fractionation.

R P Hill, R S Bush.   

Abstract

Single doses or multiple fractions of 2, 3, 5 or 10 Gy were given daily to KHT Sarcomas, growing in C3H mice, in combination with a misonidazole dose of 0.5 mg/g body weight administered 30--40 min before each radiation dose. Cell survival assays were performed on groups of tumours after different total doses to determine tumour cell survival curves for each fractionation schedule. The results indicate that misonidazole is effective in sensitizing the tumours to single doses and to large dose fractions, but that the degree of sensitization declines with fraction size such that there is no difference between the survival curves obtained for 2 Gy fractions given with or without prior drug treatment. Comparison of iso-effect curves, derived from the data, with those for normal skin suggests that, even though misonidazole increases the effect of the radiation on the tumour when large dose fractions are used, the small dose fractions probably still give a better "therapeutic ratio".

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 277242      PMCID: PMC2149410     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  6 in total

1.  An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions.

Authors:  J E Thomson; A M Rauth
Journal:  Radiat Res       Date:  1974-05       Impact factor: 2.841

2.  Radiosensitizers of hypoxic cells in solid tumors.

Authors:  J F Fowler; G E Adams; J Denekamp
Journal:  Cancer Treat Rev       Date:  1976-12       Impact factor: 12.111

Review 3.  Experimental animal results relating to time-dose relationships in radiotherapy and the "ret" concept.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  1971-02       Impact factor: 3.039

4.  A lung-colony assay to determine the radiosensitivity of cells of a solid tumour.

Authors:  R P Hill; R S Bush
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1969-07

5.  Dose fractionation studies with a murine sarcoma under conditions of air or carbogen (95% O2 + 5% CO2) breathing.

Authors:  R P Hill; R S Bush
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

6.  Testing of hypoxic cell radiosensitizers in vivo.

Authors:  A M Rauth; J Chin; L Marchow; J Paciga
Journal:  Br J Cancer Suppl       Date:  1978-06
  6 in total
  4 in total

1.  Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.

Authors:  A Inui; Y S Chung; T Sawada; Y Kondo; J J Ho; Y S Kim; M Sowa
Journal:  Jpn J Cancer Res       Date:  1996-09

2.  Chemopotentiation in vivo: no loss of sensitization with fractionation.

Authors:  S A Hill; D W Siemann
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

3.  In vivo combination of misonidazole and the chemotherapeutic agent CCNU.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

4.  The quantitative response of human tumours to radiation and misonidazole.

Authors:  D V Ash; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.